BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1376806)

  • 1. Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA).
    de Muinck ED; Buchner-Moell D; van de Ven LL; Lie KI
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):870-5. PubMed ID: 1376806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
    Kohli RS; Lahiri A; Raftery EB
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S148-53. PubMed ID: 2439787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
    Maltz MB; Dymond DS; Nathan AW; Camm AJ
    Eur Heart J; 1987 Dec; 8 Suppl M():37-42. PubMed ID: 2967184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
    Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
    Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
    Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
    de Muinck E; Wagner G; vd Ven LL; Lie KI
    Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bevantolol and atenolol in chronic stable angina.
    Rodrigues EA; Lawrence JD; Dasgupta P; Hains AD; Lahiri A; Wilkinson PR; Raftery EB
    Am J Cardiol; 1988 Jun; 61(15):1204-9. PubMed ID: 2897780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris.
    Schwartz JB; Jackson G; Kates RE; Harrison DC
    Am Heart J; 1981 Apr; 101(4):380-5. PubMed ID: 6111212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol: once-daily cardioselective beta blockade for angina pectoris.
    Jackson G; Schwartz J; Kates RE; Winchester M; Harrison DC
    Circulation; 1980 Mar; 61(3):555-60. PubMed ID: 6243518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisoprolol in the treatment of angina pectoris: a double blind comparison with verapamil.
    De Divitiis O; Liguori V; Di Somma S; Brignoli M; Ferraro S; Petitto M; Fazio S; Marsullo G; Salvatore M; Gradnik R
    Eur Heart J; 1987 Dec; 8 Suppl M():43-54. PubMed ID: 2967185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)].
    Gruppillo P; Battaglia R; Masoni C; Maistrello I; Masoni A
    G Ital Cardiol; 1981; 11(12):2081-7. PubMed ID: 7049817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of atenolol and nifedipine in chronic stable angina pectoris.
    Shapiro W; Narahara KA; Kostis JB; Thandroyen F; Zohman LR
    Am J Cardiol; 1989 Jul; 64(3):186-90. PubMed ID: 2662743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
    Raftery EB; Lahiri A; Hughes LO; Rose EL
    Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
    Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
    Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
    Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.